Tuesday, 16th July RACI Biomolecular Division Conference 2013
Session 6
8:30AM - 10:40AM
Tuesday, 16th July
Wentworth
Chair: Shelli McAlpine
Sponsored by:
- Antibody-Drug Conjugates for the Treatment of Cancer - John Flygare
- Towards the Development of Bromodomain Inhibitors as Potential Cancer Therapeutics - Pat Sharp
- Examining AAL(S) as a New Lead for the Treatment of Leukaemia - Hamish D Toop
- Towards Hypoxia-Activated Anti-tumour Mutual Prodrugs: Progress and Discoveries en Route - Michael J Kelso
- Towards developing selective inhibitors of the protease Fibroblast Activation Protein (FAP) as a potential therapeutic for cancer and chronic liver injury - Mark D Gorrell
Morning Tea
10:40AM - 11:00AM
Tuesday, 16th July
Pioneers (Exhibition Hall)
Sponsored by:
Session 7
11:00AM - 1:20PM
Tuesday, 16th July
Wentworth
Chair: Rachel Codd
Sponsored by:
- Natural Products in a Drug Discovery Environment - Ronald J Quinn
- Rings, helices, macromolecular structures and the inhibition of dynamin GTPase as a novel therapeutic target - Adam McCluskey
- Identification of an antifungal inhibitor of the riboflavin synthesis pathway by in silico screening - Joel D A Tyndall
- Synthesis and evaluation of novel enzyme inhibitors as tuberculosis drug leads - Anh Thu Tran
- Exploiting Fungal Chemistry for Antimalarial Lead Discovery - Rohan A Davis
Lunch
1:20PM - 2:30PM
Tuesday, 16th July
Pioneers (Exhibition Hall)
Sponsored by:
Session 8
2:30PM - 4:10PM
Tuesday, 16th July
Wentworth
Chair: Renate Griffith
- Bio-heterocyclic chemistry, from Adrien Albert to the University of Adelaide - Andrew Abell
- Raving mad? MDMA (‘ecstasy’) analogues for the treatment of Parkinson’s disease - Matthew Piggott
- A functional nanoreactor based on a Ru(II)bisterpyridine-cytochrome c bioconjugate light driven proton pump - Pall Thordarson
Afternoon Tea
4:10PM - 4:40PM
Tuesday, 16th July
Wentworth
Session 9
4:40PM - 6:00PM
Tuesday, 16th July
Wentworth
Chair: Wim Meutermans
- A new perspective on ATP: Implications of ATP structure on the design of ATP site kinase inhibitors - Chris Parkinson
- Development of levofloxacin releasing intravitreal implants for the treatment of ocular disease - Andrew C Donohue
- Development of mechanism-based inhibitors of amine oxidases. - Alison D Findlay
- Scaffold hops to a pre-clinical candidate to treat Chagas Disease - Martine Keenan
Conference Dinner
7:00PM - 10:00PM
Tuesday, 16th July
Blaxland & Lawson
Sponsored by:
